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When I-0-heptadecyl-rat-glycerol was fed (20 mg/g of food) to 19-day-old rats for 10 days, a high incorporation of the 
heptadecyl group into the I-0-alk-l’-enyl group of ethanolamine plasmalogens of all tissues was observed. For example, 
62% of the alkenyl groups from liver plasmalogen was of the 17:O variety. The analogous values for other tissues were 
62% in kidney, 57% in lung, 57% in heart, 50% in intestine, 43% in erythrocytes, 25% in testis and 8% in brain. The cor- 
responding figures in the control rats (fed normal rat chow) were only 2-3s of 17:O for all tissues. Available evidence 
indicates that dietary 1-0-heptadecyl-sn-glycerol is utilized to form tissue plasmalogens without the cleavage of the ether 
bond. The relevance of these results to the possible dietary ether lipid therapy of patients suffering from congenital ether 
lipid deficiency is discussed. 
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1. INTRODUCTION 
It has been long known from the work of 
Blomstrand and co-workers that dietary glycerol 
ether lipids are absorbed intact from the digestive 
tract of humans and rats without the cleavage of 
the ether bond [1,2]. Later, Paltauf [3] and 
Mangold and co-workers [4,5] have shown that in 
intestinal mucosal cells, dietary 1-O-alkyl-sn- 
glycerol is metabolized to plasmalogens (l-O- 
alk-1 ’ -enyl-sn-glycerol derivatives), the major 
membrane ether lipid. However, little is known 
regarding the transport and conversion of dietary 
ether lipids to membrane ether lipids in different 
tissues other than intestine. There is a brief report 
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by Bandi and co-workers [6] who showed that, in 
rats, a small fraction of the dietary ether lipid is in- 
corporated into plasmalogens of liver. On the 
other hand, using tracer doses of radioactive ether 
lipids, a number of workers have concluded that in 
animals, exogenous ether lipids are not incor- 
porated into tissue ether lipids to any significant 
extent [7,8]. 
In recent years, the possible incorporation of 
dietary ether lipids to membrane glycerol-ether 
lipids and plasmalogens has generated much in- 
terest because of the discovery of a number of 
genetic diseases uch as Zellweger cerebrohepato- 
renal syndrome where the enzymes catalyzing the 
ether bond synthesis are deficient [9,10] and hence 
the ether lipids are found to be practically absent 
in the tissues of these patients [l 11. A preliminary 
study indicated that by supplementing the diet of 
these patients with batyl alcohol (1 -O-octadecyl- 
sn-glycerol), the erythrocytes’ plasmalogen content 
can be restored to almost normal levels [12]. 
However, nothing is known about the changes in 
the ether lipids in other tissues of these patients. 
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We, therefore, started experiments with young rats 
to investigate the incorporation of dietary 0-alkyl 
glycerol into plasmalogens of different tissues. For 
this purpose, we chose 1-0-heptadecyl glycerol, 
since the heptadecyl moiety is almost absent in 
naturally occurring ether lipids but the chain 
length resembles the chain length distribution of 
membrane ether lipids which is mainly 16 : 0, 18 : 0 
and 18 : 1. The results from these experiments, as 
reported here, show that not only is dietary hep- 
tadecyl glycerol incorporated into plasmalogens of 
all tissues but the extent of incorporation is 
remarkably high. 
2. MATERIALS AND METHODS 
n-Heptadecanol, methanesulfonyl chloride and ruc-isopro- 
pylidene glycerol were obtained from Aldrich (Milwaukee, WI). 
2,3-Isopropylidene-sn-glycerol, 1,2-isopropylidene-sn-glycerol 
and lysophosphatidyl ethanolamine were purchased from 
Sigma (St, Louis, MO). All solvents were analytical grade and 
freshly distilled before use. Other materials were the same as 
described [13]. 
I-O-Heptadecyl-rue-glycerol and its pure optical isomers 
(1-sn and 3-sn glycerols) are prepared by the condensation of 
heptadecyl methanesulfonate with the corresponding iso- 
propylidene glycerols followed by acid hydrolysis as described 
by Baumann and Mangold [14]. The purity of the final com- 
pounds was at least 98% as determined by TLC and GLC. 
Sprague-Dawley 19-day-old male rats (just after weaning), 
weighing 30-35 g, obtained from Harlan Sprague-Dawley (In- 
dianapolis, IN) were used for these studies. The animals were 
divided into groups of 4 rats. The control group was given 
powdered chow and water and the experimental group received 
the same diet but containing I-0-heptadecyl-(rue or I-sn or 
3;sn)-glycerol and water. All the groups were fed ad libitum for 
5-10 days as indicated in fig.1 and table 1. The animals con- 
sumed about 4 g food/day per rat at the beginning, which was 
increased to about 9 g/day per rat at the end (10 days) of the 
experiment. The average weight of the animals at the end (10 
days) of the experiment was 85 g. 
At the end of the feeding period, the animals were lightly 
anesthetized with ether and killed by decapitation. The blood 
and other tissues (liver, kidney, brain, testis, heart, lung and in- 
testine) were collected immediately and, if necessary, were 
stored at - 70°C. The total lipid was extracted from the pooled 
tissues of the individual classes with neutral chloroform- 
methanol (1: 1) and washed as described [13]. 
The chain length of the alkenyl group of PE plasmalogen was 
analyzed by first subjecting the total lipid extract to alkaline 
methanolysis [15], isolating the resulting 1ysoPE plasmalogen 
by TLC [13], followed by acid hydrolysis [16] and the reduction 
of the liberated aldehydes by NaBH4 to the corresponding 
alcohols [ 131. The alcohols, after converting to acetate esters 
[17], were separated according to the chain lengths by GLC. 
The GLC analyses were carried out on a Hewlett-Packard gas 
chromatograph, model 5710A, equipped with a flame ioniza- 
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tion detector and an electronic integrator (Spectra Physics). The 
alcohol acetates were analyzed on 15% Silar 1OC supported on 
Gas Chrom R in a glass-lined stainless steel analytical column 
(6 ft X 0.125 in) with temperature programming. The peaks 
were identified by comparing the retention values to that of 
known standards. 
The plasmalogen content of total lipid extracts was deter- 
mined by the two-dimensional TLC method as described by 
Horrocks [181. The lipid phosphates were measured as describ- 
ed by Bartlett [19]. Other methods were the same as described 
[13,20]. 
3. RESULTS AND DISCUSSION 
The chain length distribution patterns of the 
1-O-alk-l ’ -enyl group of the ethanolamine 
plasmalogen from different tissues of the control 
and experimental (1-O-heptadecyl-rac-glycerol- 
fed) rats are shown in fig. 1. Only the major species 
are shown here which comprise >90% of the total 
alkenyl groups of PE plasmalogen. As reported by 
many authors [21], and as is the case here, the 
chain length distribution of the alkenyl group in 
control rats constitutes mainly three isomers, i.e. 
16:0, 18 :0 and 18: 1 (fig.1). Only in intestine is 
20:0 present as an additional component (fig. l), 
which has been reported by Paltauf [3]. In con- 
trast, the alkenyl group of PE plasmalogen from 
most of the tissues of rats which were chronically 
fed 1-0-heptadecyl glycerol contained 17 : 0 as the 
major species (fig.1). The lower incorporation in 
the testis and brain is probably because testis is im- 
mature in these young rats, and the formation of 
brain myelin, the major source of brain 
plasmalogens, is almost complete before the start 
of the experiment (19-day-old rats). Administra- 
tion of alkyl glycerol to rats before the beginning 
of myelination (< lo-day-old rats) would probably 
result in a large incorporation of the exogenous 
ether lipid to brain lipids. However, it is difficult 
to feed chronic doses of ether lipids to these suckl- 
ing rats. 
Though a high amount of alkyl glycerol is fed to 
these rats, the amount of plasmalogens per g of 
tissue, measured according to the method of Hor- 
rocks [ 181, was found to be the same in the control 
and experimental animals. The incorporation of 
the dietary ether lipid into tissue plasmalogen is 
very rapid, as we observed in a separate experiment 
that feeding the same amount of heptadecyl 
glycerol per day to these young rats for only 5 days 
increased the 17 : 0 content of the alk- 1’ -enyl group 
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Fig.1. The chain length distribution of the alk-1 ‘-enyl group at 
the C-l position of PE plasmalogen from different tissues of 
rats fed either powdered food (open bars) or powdered food 
containing 2% (w/w) 1-0-heptadecyl-rat-glycerol (hatched 
bars) for 10 days. The chain lengths are indicated at the top 
panel using the usual nomenclature, i.e. number of carbon 
atoms: number of double bonds other than at the 1 ‘-position. 
of kidney and liver lipid to 50-55070. We also 
found that when fed 1% with the diet for 5 days, 
the natural isomer of the heptadecyl glycerol, i.e. 
1-0-heptadecyl-sn-glycerol is incorporated to con- 
siderable extent into tissue plasmalogens (-55% in 
liver and kidney) but the unnatural isomer, 3-0- 
heptadecyl-sn-glycerol, is incorporated only in low 
amount (-7% over the controls) in these tissues 
(table 1). A similar high (40-50%) incorporation 
of the natural 1-alkyl-sn isomer (but not the 3-m 
isomer) into tissue plasmalogens of other tissues 
(heart, lung, spleen, skeletal muscle, intestine, 
erythrocytes, etc.) was also observed (not shown). 
As found for the DL-mixture (fig.l), the incor- 
poration of the 1-sn isomer into brain lipid is also 
low but significantly higher than that from the 3-m 
isomer (table 1). These findings are similar to the 
results reported by Paltauf [3], who showed that in 
intestinal mucosal cells only the 1-m isomer of the 
1-0-octadecyl glycerol, but not the 3-m isomer, 
was incorporated into plasmalogens without the 
cleavage of the ether bond. Apparently, 1-O-alkyl- 
sn-glycerol is enzymatically converted to l-O- 
alkyl-sn-glycerol-3-phosphate [22], which is fur- 
ther stereospecifically acylated in tissues to l-O- 
alkyl-2-acyl-sn-glycerol-3-phosphate [23], the key 
precursor of glycerol ether lipids and plasmalogens 
[24]. However, the enzyme which catalyzes the ox- 
idative cleavage of ether bond of alkyl glycerol is 
not stereospecific [25], so that the administered 
3-m isomer of the alkyl glycerol is completely 
cleaved in the body to form heptadecanoic acid 
and glycerol. Our finding of a much higher incor- 
poration of the 1-m isomer compared to the 3-m 
Table 1 
Incorporation of dietary l-O- and 3-0-heptadecyl-sn-glycerol into PE plasmalogen of rat tissues 
Tissues Carbon number of alk-1 ‘enyl group (% of total) 
16:O 17:o 18:O 18:l 20:o 
1 -sn 3-sn 1 -sn 3-sn 1-sn 3-sn 1 -sn 3-M 1 -sn 3-sn 
Liver 15.8 26.3 55.3 7.3 16.9 38.3 3.8 17.0 0.5 1.2 
Kidney 17.3 32.0 55.9 7.1 15.9 31.2 7.6 17.7 0.3 2.2 
Brain 28.3 29.1 5.5 0.9 38.0 41.8 20.0 19.7 0.5 0.4 
Rats were fed (10 mg per g of powdered food) either I-0-heptadecyl-sn-glycerol (I-sn) or 3-0- 
heptadecyl-sn-glycerol (3-s@ or powdered food only (control group, not shown) for 5 days and then 
the alk-l’-enyl group compositions at the C-l of PE plasmalogen from different tissues were 
analyzed as described in the text 
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isomer indicates that only the dietary l-O- 
heptadecyl-sn-glycerol is incorporated into the 
membrane ther lipids with the ether bond remain- 
ing intact during such conversions. 
The results presented above show that in young 
animals dietary ether lipids, when fed in a chronic 
dose, are utilized by all tissues to synthesize mem- 
brane ether phosphoglycerides. The choice of hep- 
tadecyl glycerol is fortuitous because the chain 
length of the 0-alkyl group seems appropriate not 
only for the incorporation into the alkyl glycerol 
ethers but also to their dehydrogenation products, 
i.e. plasmalogens. This is in contrast to the 
findings of Weber [26] who showed that relatively 
shorter chain alkyl glycerol (1-0-dodecyl glycerol), 
when fed to the rats, is incorporated to the alkyl 
glycerol ethers but not to the plasmalogens of dif- 
ferent tissues. It seems that the very narrow and 
specific chain length distribution of the alkenyl 
group of plasmalogens is not only due to the 
specificity of the acyl CoA reductase 1271, but also 
due to the specificity of the dehydrogenase which 
catalyzes the formation of the alk-1 ‘-enyl group 
from the corresponding ethanolamine glycerol 
ethers [28]. Reports by Mangold and co-workers 
[4,6,29] also indicate that the dehydrogenase is 
very specific with respect to the chain length and 
the degree of unsaturation of the alkyl group pre- 
sent in the ether lipid. 
These findings as reported here are somewhat 
surprising because an unnatural dietary glycerol 
ether is found to be incorporated into tissues to 
such a high extent that it became the major compo- 
nent of membrane plasmalogens. This finding will 
be useful to study the physiological effects of 
changing the even numbered chain length of a 
membrane lipid to an odd numbered one and also 
to study the in vivo turnover of plasmalogens in 
tissues as the unnatural 17 :0 moiety probably 
would be recycled at a very low rate. The present 
finding has also clinical relevance to a possible 
dietary ether lipid therapy for a number of genetic 
diseases uch as Zellweger cerebrohepatorenal syn- 
drome, neonatal adrenoleukodystrophy, Refsum 
disease and Rhizomelic chondrodysplasia punc- 
tata, where there is a deficiency of ether lipids in 
all tissues [ 10,301. 
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